ATE25090T1 - Pharmazeutische verbindungen, deren herstellung, anwendung, deren zwischenverbindungen und herstellung. - Google Patents

Pharmazeutische verbindungen, deren herstellung, anwendung, deren zwischenverbindungen und herstellung.

Info

Publication number
ATE25090T1
ATE25090T1 AT83101069T AT83101069T ATE25090T1 AT E25090 T1 ATE25090 T1 AT E25090T1 AT 83101069 T AT83101069 T AT 83101069T AT 83101069 T AT83101069 T AT 83101069T AT E25090 T1 ATE25090 T1 AT E25090T1
Authority
AT
Austria
Prior art keywords
preparation
compounds
sup
pharmaceutical
intermediate compounds
Prior art date
Application number
AT83101069T
Other languages
English (en)
Inventor
Lawrence Alfred Lowe
Samuel Wilkinson
Terence William Smith
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE25090T1 publication Critical patent/ATE25090T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/665—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • C07K14/70—Enkephalins
    • C07K14/702—Enkephalins with at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT83101069T 1982-02-05 1983-02-04 Pharmazeutische verbindungen, deren herstellung, anwendung, deren zwischenverbindungen und herstellung. ATE25090T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8203462 1982-02-05
EP83101069A EP0085963B1 (de) 1982-02-05 1983-02-04 Pharmazeutische Verbindungen, deren Herstellung, Anwendung, deren Zwischenverbindungen und Herstellung

Publications (1)

Publication Number Publication Date
ATE25090T1 true ATE25090T1 (de) 1987-02-15

Family

ID=10528158

Family Applications (1)

Application Number Title Priority Date Filing Date
AT83101069T ATE25090T1 (de) 1982-02-05 1983-02-04 Pharmazeutische verbindungen, deren herstellung, anwendung, deren zwischenverbindungen und herstellung.

Country Status (9)

Country Link
US (1) US4489062A (de)
EP (1) EP0085963B1 (de)
JP (1) JPS58146541A (de)
AT (1) ATE25090T1 (de)
AU (1) AU566643B2 (de)
CA (1) CA1248299A (de)
DE (1) DE3369327D1 (de)
NZ (1) NZ203187A (de)
ZA (1) ZA83762B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4935242A (en) * 1984-10-05 1990-06-19 Warner-Lambert Company Novel drug delivery system for expectorants
GB8616741D0 (en) * 1986-07-09 1986-08-13 Wellcome Found Pharmacologically active compounds
US5660833A (en) * 1996-06-05 1997-08-26 Medenica; Rajko D. Anti-tussive composition
US6372717B1 (en) * 1996-08-23 2002-04-16 Sederma S.A. Synthetic peptides and their use in cosmetic or dermopharmaceutical compositions
US20110268741A1 (en) * 2009-01-05 2011-11-03 The Johns Hopkins University Immunotherapy for Contact Dermatitis Using Co-Signal Regulation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254106A (en) * 1976-01-26 1981-03-03 Burroughs Wellcome Co. Biologically active amides
US4127534A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel tripeptides, intermediates therefor and pharmaceutical compositions and methods employing said tripeptides
US4127531A (en) * 1977-06-16 1978-11-28 Coy David Howard Novel hexapeptides, intermediates therefor, and compositions and methods employing said hexapeptides
JPS5424850A (en) * 1977-07-22 1979-02-24 Wellcome Found Peptide compound
GB1604850A (en) * 1977-11-24 1981-12-16 Wellcome Found Biologically active peptides
US4178371A (en) * 1977-12-15 1979-12-11 Reckitt & Colman Products Limited Tetrapeptide derivatives
US4213968A (en) * 1978-06-05 1980-07-22 Coy David Howard Enkephalin derivatives
US4288432A (en) * 1979-06-12 1981-09-08 Richter Gedeon Vegyeszeti Gyar Rt. Novel enkephalin analogs and process for the preparation thereof
HU178004B (en) * 1979-06-12 1982-02-28 Gyogyszerkutato Intezet Process for preparing new encephaline derivatives
US4351763A (en) * 1979-12-17 1982-09-28 Eli Lilly And Company Pharmacologically active peptides

Also Published As

Publication number Publication date
EP0085963A3 (en) 1983-11-23
NZ203187A (en) 1986-05-09
US4489062A (en) 1984-12-18
DE3369327D1 (en) 1987-02-26
EP0085963A2 (de) 1983-08-17
CA1248299A (en) 1989-01-03
JPS58146541A (ja) 1983-09-01
EP0085963B1 (de) 1987-01-21
AU1115583A (en) 1983-08-11
ZA83762B (en) 1984-09-26
AU566643B2 (en) 1987-10-29

Similar Documents

Publication Publication Date Title
MX171191B (es) Composiciones farmaceuticas de glipizida
MX9700081A (es) Composiciones farmaceuticas de tacrina.
AU582182B2 (en) Antidiarryheal compositions and use thereof
ATE67505T1 (de) Tetrapyrrolverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
RU95107881A (ru) Фармацевтическая композиция для лечения аллергических заболеваний, способ антигистаминного лечения, применение композиции для получения лекарственного препарата
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
KR920002144A (ko) 아연 l-카르노신 염 또는 이의 착화합물을 유효성분으로 함유하는 염증성 장질환 예방 및 치료제
DK258884D0 (da) Peptider og farmaceutisk praeparat indeholdende et saadant peptid
ES2026304A6 (es) Procedimiento de fabricacion de una forma de dosificacion de nicardipina.
KR890006227A (ko) 페놀-함유 진해성 액체 조성물
ATE25090T1 (de) Pharmazeutische verbindungen, deren herstellung, anwendung, deren zwischenverbindungen und herstellung.
JPS6483020A (en) Medicinal composition for preventing or treating aids
KR930003913A (ko) 덱스트로메토르판의 진해효과를 증진시키기 위한 방법 및 약제학적 조성물
IL126795A (en) Pharmaceutical compositions for the treatment of substance abuse disorders comprising pyridyl- and pyrimidyl-piperazines
SE8304818D0 (sv) A medicine having anti-ulcer, spasmolytic and locally anesthetic effect
KR920002163A (ko) 의약을 제조하기 위해 중추 신경 작용성 acth 유사체를 사용하는 방법